Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequenced Dacarbazine and Carmustine in Metastatic Melanoma
NCT01692691Phase 2Terminated
- Sponsor
- Western Regional Medical Center
- Start
- Aug 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dacarbazine, carmustine in melanoma, sponsored by Western Regional Medical Center. Started Aug 2012; status: terminated.
02
Drugs
dacarbazinecarmustine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01692691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01692691.